Shanghai Pharmaceuticals Holding Co., Ltd (601607.SS)
CNY 21.67
(0.18%)
CNY 21.67
(0.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 260.29 Billion | 231.98 Billion | 215.82 Billion | 191.9 Billion | 186.56 Billion | 159.08 Billion |
| Cost of Revenue | 229.36 Billion | 201.49 Billion | 187.28 Billion | 164.47 Billion | 159.75 Billion | 136.52 Billion |
| Gross Profit | 30.92 Billion | 30.48 Billion | 28.54 Billion | 27.43 Billion | 26.81 Billion | 22.56 Billion |
| Operating Expenses | 23.26 Billion | 21.7 Billion | 20.61 Billion | 19.29 Billion | 18.88 Billion | 16.32 Billion |
| Selling, General and Administrative Expenses | 19.76 Billion | 15.47 Billion | 14.72 Billion | 14.18 Billion | 14.23 Billion | 12.24 Billion |
| Research and Development Expenses | 2.2 Billion | 2.11 Billion | 1.98 Billion | 1.65 Billion | 1.34 Billion | 1.06 Billion |
| Other Expenses | 1.29 Billion | 4.11 Billion | 3.9 Billion | 3.45 Billion | 3.29 Billion | 144.34 Million |
| Cost and Expenses | 252.62 Billion | 223.2 Billion | 207.89 Billion | 183.77 Billion | 178.63 Billion | 152.84 Billion |
| Operating Income | 8.19 Billion | 9.01 Billion | 8.2 Billion | 7.18 Billion | 8.92 Billion | 5.2 Billion |
| Interest Expense | 1.66 Billion | 1.68 Billion | 1.51 Billion | 1.41 Billion | 1.4 Billion | 1.2 Billion |
| Income Tax Expense | 1.88 Billion | 1.81 Billion | 1.86 Billion | 1.57 Billion | 1.43 Billion | 887.11 Million |
| Earnings before Tax | 7.05 Billion | 8.8 Billion | 8.14 Billion | 7.17 Billion | 6.26 Billion | 5.34 Billion |
| Net Income | 3.76 Billion | 5.61 Billion | 5.09 Billion | 4.49 Billion | 4.08 Billion | 3.88 Billion |
| Earnings Per Share Basic | 1.02 | 1.61 | 1.79 | 1.58 | 1.44 | 1.37 |
| Earnings Per Share Diluted | 1.02 | 1.61 | 1.79 | 1.58 | 1.44 | 1.37 |
| Weighted Average Shares Outstanding | 3.69 Billion | 3.48 Billion | 2.84 Billion | 2.84 Billion | 2.84 Billion | 2.82 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3.7 Billion | 3.48 Billion | 2.84 Billion | 2.84 Billion | 2.84 Billion | 2.83 Billion |
| Gross Margin | 0.12 | 0.13 | 0.13 | 0.14 | 0.14 | 0.14 |
| EBIT Margin | 0.04 | 0.05 | 0.06 | 0.06 | 0.06 | 0.06 |
| Profit Margin | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| EBITDA | 11.24 Billion | 12.25 Billion | 10.54 Billion | 9.93 Billion | 9.34 Billion | 6.72 Billion |
| Earnings Before Tax Margin | 0.03 | 0.04 | 0.04 | 0.04 | 0.05 | 0.03 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 70.21 Billion | 69.06 Billion | 69.94 Billion | 62.59 Billion | 259.55 Billion | 64.91 Billion |
| Cost of Revenue | 63.2 Billion | 61.52 Billion | 62.12 Billion | 55.82 Billion | 230.52 Billion | 58.01 Billion |
| Gross Profit | 7 Billion | 7.54 Billion | 7.81 Billion | 6.77 Billion | 29.03 Billion | 6.9 Billion |
| Operating Expenses | 4.69 Billion | 5.04 Billion | 5.42 Billion | 5.86 Billion | 20.83 Billion | 4.72 Billion |
| Selling, General and Administrative Expenses | 8.59 Billion | 4.43 Billion | 4.95 Billion | 4.58 Billion | - | 6.21 Billion |
| Research and Development Expenses | 511.12 Million | 543.74 Million | 501.45 Million | 682.79 Million | - | 441.73 Million |
| Other Expenses | -4.41 Billion | -63.75 Million | 27.22 Million | -595.19 Million | -309.95 Million | -209.51 Million |
| Cost and Expenses | 67.89 Billion | 66.56 Billion | 67.55 Billion | 61.68 Billion | 251.36 Billion | 62.73 Billion |
| Operating Income | 1.83 Billion | 2.5 Billion | 2.39 Billion | 910.49 Million | 8.19 Billion | 1.99 Billion |
| Interest Expense | 585.81 Million | 329.31 Million | 471.67 Million | 423.69 Million | 1.88 Billion | 498.82 Million |
| Income Tax Expense | 396.42 Million | 673.52 Million | 551.12 Million | 322.49 Million | 1.88 Billion | 448.43 Million |
| Earnings before Tax | 1.82 Billion | 2.24 Billion | 2.21 Billion | 495.89 Million | 6.92 Billion | 1.98 Billion |
| Net Income | 1.11 Billion | 1.39 Billion | 1.54 Billion | -28.77 Million | 3.76 Billion | 1.18 Billion |
| Earnings Per Share Basic | 0.30 | 0.38 | 0.42 | -0.01 | - | 0.32 |
| Earnings Per Share Diluted | 0.30 | 0.38 | 0.42 | -0.01 | - | 0.32 |
| Weighted Average Shares Outstanding | 3.7 Billion | 3.7 Billion | 3.7 Billion | 3.7 Billion | 3.7 Billion | 3.7 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3.7 Billion | 3.7 Billion | 3.7 Billion | 3.7 Billion | 3.7 Billion | 3.7 Billion |
| Gross Margin | 0.10 | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 |
| EBIT Margin | 0.03 | 0.05 | 0.04 | 0.02 | - | 0.03 |
| Profit Margin | 0.02 | 0.02 | 0.02 | -0.00 | 0.01 | 0.02 |
| EBITDA | 2.4 Billion | 3.12 Billion | 2.99 Billion | 1.5 Billion | - | 2.24 Billion |
| Earnings Before Tax Margin | 0.03 | 0.04 | 0.03 | 0.01 | 0.03 | 0.03 |
DND
600623
ESQ
LIFD
6662
186A